Bryant, ARNCT07863193Now EnrollingIRB Ready

Acne Vulgaris Clinical Trial in Bryant, AR

Access cutting-edge acne vulgaris treatment through this phase 3 clinical trial at a research site in Bryant. Study-provided care at no cost to qualified participants.

Sponsored by Sagimet Biosciences Inc.

Quick Self-Assessment

See if you qualify for this Bryant location

Preparing your pre-screening questions…

Expert Care in Bryant

Access acne vulgaris specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related acne vulgaris treatment provided free

Apply for This Bryant Location

Check if you qualify for this acne vulgaris clinical trial in Bryant, AR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Bryant

    Convenient for AR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Bryant site if eligible
  4. 4Begin participation

About This Acne Vulgaris Study in Bryant

The purpose of this study is to evaluate the safety and efficacy of denifanstat compared with matching placebo in participants with moderate to severe acne vulgaris who are ≥12 years of age. After the 12-week treatment phase, a subset of approximately 530 participants will have the option to consent to an open-label extension phase for an additional 40 weeks of treatment.

Sponsor: Sagimet Biosciences Inc.

Who Can Participate

Inclusion Criteria

Must be willing and able to participate in the trial and provide written informed consent or assent
Aged ≥12 years on the date that written informed consent/ assent is provided
Moderate to severe acne vulgaris based on the following criteria at screening:
The EGSS at screening of 3 or 4. AND
Number of facial skin lesions:
30 to 75 inflammatory lesions
30 to 100 noninflammatory lesions
All participants with their partners, if any, must agree to the use of an acceptable method of highly effective contraception. Women of childbearing potential (WOCBP) must not be pregnant or breastfeeding, must not plan to become pregnant during the study, and must use 2 forms of birth control, one being a barrier method, or be sexually abstinent.

Exclusion Criteria

Presence of \>2 facial cysts/ nodules
Cystic acne, acne fulminans or acne conglobata
Other significant skin diseases that may affect the efficacy evaluation or require co-treatment
History of clinically significant dry eye, such as Ocular Surface Disease Index (OSDI) ≥33, or corneal staining ≥ grade III on Oxford Grading Scale, chronic dry eye, or other corneal abnormality
Use of concomitant strong cytochrome P450 (CYP) 3A4 inducers and strong or moderate inhibitors within 2 weeks prior to Day 1 the trial except Paxlovid®
Use of a glucagon-like-peptide 1 (GLP-1) agonist for \<12 weeks prior to first dose of trial medication
Use of any of the following:
Introduction of any drug known to prolong QT interval corrected for heart rate (QTC)
Sensitive substrates of P-glycoprotein (P-gp) and breast cancer resistant protein (BCRP)
Herbs and supplements such as St John's Wort or grapefruit juice.
Use of concomitant acne treatments unless appropriate washout period is documented

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Bryant?

Yes, this clinical trial (NCT07863193) has an active research site in Bryant, AR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Acne Vulgaris Treatment Options in Bryant, AR

If you're searching for acne vulgaris treatment options in Bryant, AR, this clinical trial (NCT07863193) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Bryant research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced acne vulgaris specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all acne vulgaris clinical trials near you to find additional studies recruiting in your area.

More Acne Trials in Bryant, AR

See all acne clinical trials recruiting in Bryant — not just this study.

Browse Acne Trials in Bryant →

Browse More Trials by Condition

Acne TrialsGeographic Atrophy TrialsAll Conditions →

Ready to Join in Bryant?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Bryant, AR